accounttests for the treatment of such serious neurodegenerative diseases as Parkinson���s, Huntington���s, Alzheimer���s, ALS, and multiple sclerosis. Under the terms of the deal, Elan will invest $20 million upfront in Proteostasis and may provide an...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Drug stocks gain; Derma, Elan climb
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account